| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Accidental nystatin poisoning (disorder) |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Intentional nystatin poisoning |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| intoxication par la nystatine d'intention indéterminée |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to nystatin |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin overdose |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Accidental nystatin overdose |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Intentional nystatin overdose |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| surdose de nystatine d'intention indéterminée |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 500000 unit oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin GF/LF/SF 100,000units/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100,000units pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100,000units pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing nystatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing nystatin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin 100 unit/mg cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Poisoning by nystatin |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin 100,000 units/ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Product containing clobetasone butyrate and nystatin and oxytetracycline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Clobetasone butyrate+oxytetracycline+nystatin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Accidental nystatin poisoning (disorder) |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Intentional nystatin poisoning |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydrocortisone and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing nystatin in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorhexidine and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Allergy to nystatin |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clobetasol and neomycin and nystatin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin 100000 unit/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing clobetasone and nystatin and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorhexidine and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin- and tolnaftate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clobetasol and neomycin and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clobetasol and neomycin and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clobetasone and nystatin and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Chlorhexidine and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Metronidazole and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Hydrocortisone and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nystatin and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nystatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nystatin in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Clobetasol and neomycin and nystatin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only chlorhexidine and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 500000 unit oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 500000 unit oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100 unit/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100 unit/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100 unit/mg cutaneous powder |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100 unit/mg cutaneous powder |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 200000 unit oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 200000 unit oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
| Nystatin 100000 unit vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nystatin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]